Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13 Rectal Neoplasms 10 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Uterine Cervical Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Adenocarcinoma Of Esophagus 5 Squamous Cell Carcinoma of Head and Neck 4 Neuroblastoma 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Colonic Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Multiple Myeloma 2 Melanoma 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2

Interventions

Radiotherapy 2 Radiation 2 relugolix 1 histrelin 1 darolutamide 1 bicalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Triptorelin Pamoate 1 Salicylic Acid 1 Radiation Dose Hypofractionation 1 Neoadjuvant Therapy 1 Leuprolide 1 Goserelin 1 Flutamide 1 Buserelin 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostate Adenocarcinoma × Neoadjuvant Therapy × Clear all

NCT02175212 2020-11-20

AADLPC

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡